Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria, Swiss AGO, BGOG, CEEGOG, GEICO, and SFOG regarding the use of hyperthermic intraperitoneal chemotherapy (HIPEC) in epithelial ovarian cancer

  1. Harter, P.
  2. Bogner, G.
  3. Chiva, L.
  4. Cibula, D.
  5. Concin, N.
  6. Fotopoulou, C.
  7. Gonzalez-Martin, A.
  8. Guyon, F.
  9. Heinzelmann-Schwarz, V.
  10. Kridelka, F.
  11. Mahner, S.
  12. Marmé, F.
  13. Marth, C.
  14. Morice, P.
  15. Novák, Z.
  16. Papadia, A.
  17. Ray-Coquard, I.
  18. Redecha, M.
  19. Redondo, A.
  20. Schwameis, R.
  21. Sehouli, J.
  22. Undurraga, M.
  23. Van Gorp, T.
  24. Vergote, I.
Journal:
Bulletin du Cancer

ISSN: 1769-6917 0007-4551

Year of publication: 2024

Volume: 111

Issue: 3

Pages: 277-284

Type: Review

DOI: 10.1016/J.BULCAN.2023.02.011 GOOGLE SCHOLAR

Sustainable development goals